多学科癌症会议（MCC）是治疗患有复杂健康问题的患者的重要工具，有助于临床医生在肿瘤实践中实现最佳效果。为了探讨病理学家在MCC中的作用，我们对这个主题进行了先前研究的回顾性研究。 我们通过在MEDLINE、EMBASE和Cochrane图书馆中搜索英语语言的定性、定量或多元/混合方法研究来进行范围性回顾研究，以研究病理学家在MCC中的作用和影响。我们使用Microsoft Excel来提取数据。 在76个研究结果中，我们只包括了3个研究，这些研究涉及病理学家对MCC中的癌症病例的回顾。所有3项研究都显示，专家病理学回顾提高了诊断的准确性并精细了疾病分期，导致黑色素瘤、乳腺癌和妇科癌症管理的改变。没有研究探讨病理学家参与MCC的障碍或用于促进或支持病理学家参与的策略或干预措施。 我们发现有关病理学家在MCC中的作用的研究数量很少。考虑到涉及病理学家的MCC对诊断的准确性和治疗的优化产生积极影响，未来需要进一步研究病理学家在MCC中的作用和影响以及如何促进或支持病理学家的参与。 ©2023年作者（S）。由牛津大学出版社代表美国临床病理学会出版。版权所有。欲获得许可，请发送电子邮件至：journals.permissions@oup.com。

Multidisciplinary cancer conferences (MCCs) are important tools in the treatment of patients with complex health issues, helping clinicians achieve optimal outcomes in oncological practice. To explore the role of pathologists at MCCs, we conducted a review of prior research on this topic.We conducted a scoping review by searching MEDLINE, EMBASE, and the Cochrane Library for English-language qualitative, quantitative, or multiple/mixed methods studies on the role and impact of pathologists on MCCs. We used Microsoft Excel to extract data.Of 76 research results, we included only 3 studies that involved review of cancer cases by pathologists for MCCs. All 3 studies showed that expert pathology review improved the accuracy of diagnosis and refined disease staging, leading to changes in the management of melanoma, breast cancer, and gynecologic cancer. No studies explored the barriers to pathologists participating in MCCs or the strategies or interventions employed to promote or support pathologist involvement.We identified a paucity of studies on the role of pathologists in MCCs. Given the positive impact of MCCs involving pathologists on the accuracy of diagnosis and optimization of treatment, future research is warranted to further establish the role and impact of pathologists in MCCs and how to promote or support pathologists' involvement.© The Author(s) 2023. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.